E903-0627 Screening compound: 1-(1-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine-4-carbonyl)-4-(pyridin-2-yl)piperazine

E903-0627 Screening compound: 1-(1-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine-4-carbonyl)-4-(pyridin-2-yl)piperazine
E903-0627 Screening compound: 1-(1-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine-4-carbonyl)-4-(pyridin-2-yl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound E903-0627
1-(1-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine-4-carbonyl)-4-(pyridin-2-yl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E903-0627

Molecular Formula

C26H32N6O4 (C26 H32 N6 O4)

Compound Name

1-(1-{[3-(3,4-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine-4-carbonyl)-4-(pyridin-2-yl)piperazine

IUPAC name

1-(1-{[3-(34-dimethoxyphenyl)-124-oxadiazol-5-yl]methyl}piperidine-4-carbonyl)-4-(pyridin-2-yl)piperazine

SMILES

COc(ccc(-c1noc(CN(CC2)CCC2C(N(CC2)CCN2c2ncccc2)=O)n1)c1)c1OC

InChI

InChI=1S/C26H32N6O4/c1-34-21-7-6-20(17-22(21)35-2)25-28-24(36-29-25)18-30-11-8-19(9-12-30)26(33)32-15-13-31(14-16-32)23-5-3-4-10-27-23/h3-7,10,17,19H,8-9,11-16,18H2,1-2H3

InChI Key

PZQOBPURWWAPMZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14926974

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.017

Distribution Coefficient, logD

2.873

Water Solubility, LogSw

-3.06

Polar Surface Area

78.995

Acid Dissociation Constant (pKa)

23.93

Base Dissociation Constant (pKb)

7.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

E903-0627 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E903-0627 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E903-0627?
Check Price and Availability of E903-0627, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E903-0627 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E903-0627
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E903-0627
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E903-0627 available by request